Improved consistency in dosing anti-tuberculosis drugs in Taipei, Taiwan.

PLoS One

International Union Against Tuberculosis and Lung Disease, Paris, France.

Published: February 2013

AI Article Synopsis

  • In Taipei City, the percentage of tuberculosis (TB) patients with recorded pre-treatment body weight significantly increased from 64.5% in 2003 to 96.5% from 2007-2010, indicating improved documentation and monitoring.
  • The consistency in dosages for anti-TB medications, particularly in fixed-dose combinations, also rose during this period, suggesting the effectiveness of interventions from the Taiwan CDC.
  • Despite improvements, some patients, especially those under 50 kg, still received higher-than-recommended doses of rifampicin, highlighting the need for continued attention to individual patient factors in prescribing practices.

Article Abstract

Background: It was reported that 35.5% of tuberculosis (TB) cases reported in 2003 in Taipei City had no recorded pre-treatment body weight and that among those who had, inconsistent dosing of anti-TB drugs was frequent. Taiwan Centers for Disease Control (CDC) have taken actions to strengthen dosing of anti-TB drugs among general practitioners. Prescribing practices of anti-TB drugs in Taipei City in 2007-2010 were investigated to assess whether interventions on dosing were effective.

Methodology/principal Findings: Lists of all notified culture positive TB cases in 2007-2010 were obtained from National TB Registry at Taiwan CDC. A medical audit of TB case management files was performed to collect pretreatment body weight and regimens prescribed at commencement of treatment. Dosages prescribed were compared with dosages recommended. The proportion of patients with recorded pre-treatment body weight was 64.5% in 2003, which increased to 96.5% in 2007-2010 (p<0.001). The proportion of patients treated with consistent dosing of a 3-drug fixed-dose combination (FDC) increased from 73.9% in 2003 to 87.7% in 2007-2010 (p<0.001), and that for 2-drug FDC from 76.0% to 86.1% (p = 0.024), for rifampicin (RMP) from 62.8% to 85.5% (p<0.001), and for isoniazid from 87.8% to 95.3% (p<0.001). In 2007-2010, among 2917 patients treated with either FDCs or RMP in single-drug preparation, the dosage of RMP was adequate (8-12 mg/kg) in 2571(88.1%) patients, too high in 282(9.7%), too low in 64(2.2%). In multinomial logistic regression models, factors significantly associated with adequate dosage of RMP were body weight and preparations of RMP. Patients weighting <40 kg (relative risk ratio (rrr) 6010.5, 95% CI 781.1-46249.7) and patients weighting 40-49 kg (rrr 1495.3, 95% CI 200.6-11144.6) were more likely to receive higher-than-recommended dose of RMP.

Conclusions/significance: Prescribing practice in the treatment of TB in Taipei City has remarkably improved after health authorities implemented a series of interventions.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3428337PMC
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0044133PLOS

Publication Analysis

Top Keywords

body weight
12
anti-tb drugs
12
drugs taipei
8
taipei city
8
recorded pre-treatment
8
pre-treatment body
8
dosing anti-tb
8
improved consistency
4
dosing
4
consistency dosing
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!